CIRS Receives $1.09M from Bill & Melinda Gates Foundation to continue their Philanthropic Services.

▴ CIRS Receives $1.09M from Bill & Melinda Gates Foundation to continue their Philanthropic Services
Centre for Innovation in Regulatory Science Awarded a $1.09m Grant to Help Accelerate Registration of Medicines in Low and Middle Income Countries

The Centre for Innovation in Regulatory Science (CIRS), a neutral and independent, international member-based organisation headquartered in the UK, has been awarded a phase two grant of $1.09m by the Bill & Melinda Gates Foundation to continue their collaborative endeavours to expedite patient access to medicines in specific areas of greatest medical need in Low and Middle Income Countries.

The grant has been awarded to CIRS for the purpose of 'Tracking Regulatory Performance Metrics in Low and Middle Income Countries' to accelerate and consolidate the activities around a unique metrics collection programme which aims to assist LMICs achieve targeted improvements in regulatory performance goals and ultimately, to accelerate registration of quality medicines in these countries.

Regulators in LMICs strive to develop fit-for-purpose regulatory systems, in particular, those related to the review, assessment and approval of medicines, including vaccines. Inefficiencies, especially redundancies, in the process can translate into long and unpredictable review times for medicines, resulting in delays to their registration. These inefficiencies can also affect the authorisation of competitive generic and biosimilar products, which has an impact on the costs and availability of many medicines.

CIRS has collected regulatory marketing authorisation assessment data for more than 20 years, especially in high-income countries, and has developed a standardised reporting approach to identify key characteristics that may impact regulatory performance to allow accurate interpretation of the metrics being evaluated. With such data, regulatory authorities have been able to continually improve their performance against their own goals and against the performance of peer agencies.

Through CIRS' OpERA programme (Optimising Efficiencies in Regulatory Agencies) it combines qualitative and quantitative information to provide a detailed picture of the regulatory assessment activities of agencies at any stage of maturity and provides each country with a country report which permits global comparisons to similar agencies and encourages the sharing and adoption of good review practices.

The grant will also allow CIRS to provide opportunities for emerging national regulatory agencies to come together at regional forums in Africa, Latin America, and Asia during the three years of the grant. The sharing of experiences is a key way that regulators identify important new ways to improve their organisational efficiency and learn about tools and processes that will help build best regulatory assessment practices.

Jamie Munro, Executive Director, CIRS said: "The efficient, predictable, and speedy assessment and introduction of quality new medicines and vaccines to underserved patient populations continues to be a priority for the whole healthcare community. The aims of phase two of this programme are to give regulatory agencies in LMICs the tools and information to measure themselves against the outcomes of their evolving product assessment processes; whilst transitioning the OpERA programme to a financially self-sustainable performance metric monitoring system for the ongoing use of participating agencies."

Africa: Ethiopia, East African Community (EAC), Zazibona initiative (in particular, the original members: Zambia, Zimbabwe, Botswana & Namibia), West Africa Health Organisation (WAHO – in particular Ghana, Nigeria, Burkina Faso & Senegal) and the South African Health Products Regulatory Authority (SAHPRA).

Latin America: Brazil, Mexico, Peru, Haiti, CARICOM (Caribbean Community).

Asia/Middle East: India, Indonesia, Vietnam, Malaysia, Philippines, Singapore, Thailand, China, Gulf Health Council (GHC).

Tags : #Centreforinnovationinregulatoryscience #Billandmelindagatesfoundation #Patientaccess

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Sexual wellness superstore, Love Depot launches digital campaign to deliver every desireMarch 28, 2024
Recharge Your Life: Simple Ways to Boost Your Physical and Mental EnergyMarch 28, 2024
The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024
Surmandal's Tribute to the Legends of Hindustani Classical MusicMarch 26, 2024
In Moscow, over 350,000 mammograms have been analyzed using artificial intelligence as part of the compulsory health insurance programMarch 26, 2024
Embark on a Creative Journey: "Kala For A Cause" Unveils Pottery Workshop Series March 26, 2024
Healthtech pioneer Aurora Innovation appoints new CEO – expands in Europe with service that streamlines patient-healthcare interactionMarch 26, 2024
In A Rare Feat, 45 YO Woman Walks Within 6 Hrs. Of Dual Robotic Surgery In A Single Operation At HCGMCCMarch 26, 2024
Improve Cancer Care through Automated CT Analysis: Oncoshield – CTMarch 26, 2024